BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18175100)

  • 1. The effect of altered physiological states on intravenous anesthetics.
    Henthorn TK
    Handb Exp Pharmacol; 2008; (182):363-77. PubMed ID: 18175100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Special aspects of pharmacokinetics of inhalation anesthesia.
    Hendrickx JF; De Wolf A
    Handb Exp Pharmacol; 2008; (182):159-86. PubMed ID: 18175091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early drug distribution: a generally neglected aspect of pharmacokinetics of particular relevance to intravenously administered anesthetic agents.
    Henthorn TK; Krejcie TC; Avram MJ
    Clin Pharmacol Ther; 2008 Jul; 84(1):18-22. PubMed ID: 18563069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed-effects modeling of the influence of midazolam on propofol pharmacokinetics.
    Vuyk J; Lichtenbelt BJ; Olofsen E; van Kleef JW; Dahan A
    Anesth Analg; 2009 May; 108(5):1522-30. PubMed ID: 19372331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of PK/PD modeling to intravenous anesthesia.
    Minto CF; Schnider TW
    Clin Pharmacol Ther; 2008 Jul; 84(1):27-38. PubMed ID: 18463625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, efficacy, and tolerability of fentanyl following intranasal versus intravenous administration in adults undergoing third-molar extraction: a randomized, double-blind, double-dummy, two-way, crossover study.
    Christrup LL; Foster D; Popper LD; Troen T; Upton R
    Clin Ther; 2008 Mar; 30(3):469-81. PubMed ID: 18405786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of intravenously administered anesthetic drugs: concepts and lessons for drug development.
    Kern SE; Stanski DR
    Clin Pharmacol Ther; 2008 Jul; 84(1):153-7. PubMed ID: 18463623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologically based pharmacokinetics (PBPK).
    Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
    Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of general anesthesia on whole body and regional pharmacokinetics of local anesthetics at toxic doses.
    Copeland SE; Ladd LA; Gu XQ; Mather LE
    Anesth Analg; 2008 May; 106(5):1440-9, table of contents. PubMed ID: 18420858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronomedicine: its achievements and objectives].
    Komarov FI; Rapoport SI
    Ter Arkh; 1988; 60(8):12-7. PubMed ID: 3227477
    [No Abstract]   [Full Text] [Related]  

  • 11. The pharmacokinetics and pharmacodynamics of alfaxalone in cats after single and multiple intravenous administration of Alfaxan at clinical and supraclinical doses.
    Whittem T; Pasloske KS; Heit MC; Ranasinghe MG
    J Vet Pharmacol Ther; 2008 Dec; 31(6):571-9. PubMed ID: 19000281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic-pharmacodynamic modeling in anesthesia, intensive care and pain medicine.
    Sadean MR; Glass PS
    Curr Opin Anaesthesiol; 2009 Aug; 22(4):463-8. PubMed ID: 19412091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics of sevoflurane in conjunction with the AnaConDa: toward target-controlled infusion of volatiles into the breathing system.
    Enlund M; Kietzmann D; Bouillon T; Züchner K; Meineke I
    Acta Anaesthesiol Scand; 2008 Apr; 52(4):553-60. PubMed ID: 18339161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aging issues in drug disposition and efficacy.
    Sitar DS
    Proc West Pharmacol Soc; 2007; 50():16-20. PubMed ID: 18605223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of imatinib mesylate and its metabolite in children and young adults.
    Menon-Andersen D; Mondick JT; Jayaraman B; Thompson PA; Blaney SM; Bernstein M; Bond M; Champagne M; Fossler MJ; Barrett JS
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):229-38. PubMed ID: 18398615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect site modelling and its application in TCI.
    Mortier E; Struys M
    Acta Anaesthesiol Belg; 2000; 51(2):149-52. PubMed ID: 11000911
    [No Abstract]   [Full Text] [Related]  

  • 18. A PC-based graphical simulator for physiological pharmacokinetic models.
    Wada DR; Stanski DR; Ebling WF
    Comput Methods Programs Biomed; 1995 Apr; 46(3):245-55. PubMed ID: 7656558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of human oral pharmacokinetics using nonclinical data: examples involving four proprietary compounds.
    Fura A; Vyas V; Humphreys W; Chimalokonda A; Rodrigues D
    Biopharm Drug Dispos; 2008 Nov; 29(8):455-68. PubMed ID: 18989850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.
    Chhun S; Jullien V; Rey E; Dulac O; Chiron C; Pons G
    Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.